Efficacy News and Research

RSS

CID trials: Adoption of new recommendations could get innovative treatments to patients faster

Complex Innovative Design trials could be transformed for the better, following the publication of recommendations, published today in the British Journal of Cancer.

6 Jan 2020

Researchers study new immunogenic properties of already existing anti-cancer drugs

The world scientific community is waging a difficult and prolonged war on cancer. New research in the field of immunogenic cell death can extend the area of drugs application and ensure patients' protection from relapse after therapy.

3 Jan 2020

Mount Sinai awarded more than $10 million in federal funding for research on glioblastoma

The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai has received more than $10 million in federal funding for several projects focusing on brain tumor research.

2 Jan 2020

Intravenous BCG vaccine provides greater protection against tuberculosis

Researchers have found that the BCG vaccine is more efficacious in the prevention of TB when administered intravenously.

2 Jan 2020

Promega and MilliporeSigma sign license agreement to expand the potential of CRISPR

Promega announce license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing technology.

From Promega Corporation 2 Jan 2020

GlobalData: Asia-Pacific seasonal influenza vaccine market set to reach US$1bn by 2028

The size of the seasonal influenza vaccine market across the three major Asia-Pacific (APAC) growth markets (3GM) will grow at a modest compound annual growth rate (CAGR) of 1.4% from US$914m in 2018 to US$1.05bn in 2028, says GlobalData, a leading data and analytics company.

2 Jan 2020

Intravenous administration boosts protective power of TB vaccine

Worldwide, more people die from tuberculosis than any other infectious disease, even though the vast majority were vaccinated.

2 Jan 2020

Scientists identify molecules capable of inhibiting DNA methylation, effectively killing malaria parasites

Parasites in the genus Plasmodium, which cause malaria, are transmitted to humans through bites from infected mosquitoes.

31 Dec 2019

New dementia vaccine may proceed to clinical trials after successful testing

A preventive treatment for dementia may proceed to clinical trials after successful animal testing.

31 Dec 2019

Scientists discover potential drug compounds that target common type of liver cancer

Scientists from the Cancer Science Institute of Singapore at the National University of Singapore, and the Agency for Science, Technology and Research (A*STAR)'s Genome Institute of Singapore have discovered four potential drug compounds that target hepatocellular carcinoma, the most common type of liver cancer.

30 Dec 2019

Researchers identify new insecticide resistance mechanism by mosquitoes

Researchers at LSTM have identified a completely new mechanism by which mosquitoes that carry malaria are becoming resistant to insecticide.

26 Dec 2019

California's vaccine policy improved immunization coverage

In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.

23 Dec 2019

Research shows how the hepatitis D virus copies itself

A team of researchers has discovered how one crucial step occurs in the lifecycle of the hepatitis D virus (HDV), which causes the widespread and hard to treat liver inflammation called hepatitis D. The study, which was published recently in the Journal of Virology, could help develop antiviral therapy to control this disease.

22 Dec 2019

Using hearts from hepatitis C-positive donors presents an opportunity to expand donor pool

Patients who were transplanted with hearts from hepatitis C-positive donors had comparable outcomes after one year to patients who received hearts from donors that didn't have the disease, according to a Vanderbilt University Medical Center study published in JAMA Cardiology.

22 Dec 2019

Efficacy News and Research

CID trials: Adoption of new recommendations could get innovative treatments to patients faster

Researchers study new immunogenic properties of already existing anti-cancer drugs

Mount Sinai awarded more than $10 million in federal funding for research on glioblastoma

Intravenous BCG vaccine provides greater protection against tuberculosis

Promega and MilliporeSigma sign license agreement to expand the potential of CRISPR

GlobalData: Asia-Pacific seasonal influenza vaccine market set to reach US$1bn by 2028

Intravenous administration boosts protective power of TB vaccine

Scientists identify molecules capable of inhibiting DNA methylation, effectively killing malaria parasites

New dementia vaccine may proceed to clinical trials after successful testing

Scientists discover potential drug compounds that target common type of liver cancer

Researchers identify new insecticide resistance mechanism by mosquitoes

California's vaccine policy improved immunization coverage

Research shows how the hepatitis D virus copies itself

Using hearts from hepatitis C-positive donors presents an opportunity to expand donor pool

New 'tumor-on-a-chip' can be used to find better cancer fighting drugs

Combined datasets can expedite the discovery and development of new cancer drugs

Common immune cell linked to failure of checkpoint inhibitors in lung cancer patients

New set of recommendations for clinicians to address youth vaping

FDA approves new drug to treat adults with advanced urothelial or bladder cancer

Attention training is a promising augment for anxiety in children who do not respond to CBT

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News